Covid19, Type 1 Diabetes Mellitus
Conditions
Brief summary
During the COVID-19 pandemic, the time spent at the home of patients has increased because of national quarantine policies and patients' fear of getting sick. For this reason, in this ongoing process, patients have been unable to go to work regularly due to their chronic diseases (being on administrative leave) and their fear of going out. These reasons have prevented being physically active. The aim of the study is to evaluate the physical activity level, quality of life, glucose control, anxiety, depression, fear of hypoglycemia and loneliness perceptions of patients with type 1 diabetes mellitus during the COVID-19 pandemic period and compared with healthy controls.
Interventions
OTHEROnline Survey
Online surveys will be applied to all participants
Sponsors
Gazi University
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
* Having been diagnosed with Type 1 Diabetes Mellitus * Willing to participate in the study * Participants whose native language is Turkish
Exclusion criteria
* Unwilling to participate in the study * Having a cognitive disorder * Not being literate * Individuals who do not have sufficient knowledge and functional levels to fill out the online form
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Physical activity level | Five minutes | Physical activity level using International Physical Activity Questionnaire - Short Form (IPAQ-SF) will be evaluated. |
| General Quality of life | Ten minutes | Quality of life using Short Form Health Survey (SF-36) will be evaluated. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Self-reported hypoglycemia | Last seven day | It will be questioned how many times patients have had hypoglycemic attacks (\<4 mmol/L and common symptoms) in the last 7 days. |
| Loneliness | Three minutes | Loneliness using UCLA Loneliness Scale Short Form (ULS-8) will be evaluated. |
| Depression | Three minutes | Depression using Hospital Anxiety and Depression Scale will be evaluated. |
| Dyspnea | Two minutes | Dyspnea during daily life activites using Modified Medical Research Dyspnea Scale will be evaluated. |
| Hypoglisemia fear | Five minutes | Hypoglisemia fear using Hypoglisemia Fear Survey (HFS) will be evaluated. |
| Anxiety | Three minutes | Anxiety using Hospital Anxiety and Depression Scale will be evaluated. |
Countries
Turkey (Türkiye)
Outcome results
None listed